SS Innovations International (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka

Austin, Texas, September 11th, 2026, FinanceWire

• The company has supported the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system.
• The program began with a robotic-assisted LIMA takedown, performed by SS Innovations founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva.
• Kings Hospital has completed more than 25 robotic procedures in three weeks, according to a recent company video describing the program’s early activity.
• SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter.
• The company’s second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528, pointing to rising utilization of the company’s installed base.
• The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is helping write a new chapter in Sri Lanka’s cardiac-surgery sector with the launch of the country’s first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system.

The program began with a robotic-assisted left internal mammary artery (“LIMA”) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, together with Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. The development was highlighted in a recent video from SS Innovations, which described the introduction of…

Read More>>

NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.IBN.ai

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

Corporate Communications

IBN

Austin, Texas

www.IBN.ai

512.354.7000 Office

Editor@IBN.ai